Video | TCTAP 2024

[TCTAP Workshops] Left Main and Multi-Vessel Diseases: Updated Concept and Treatment

April 25, 2024 / 2:00 PM ~ 3:50 PM 📌 Valve & Endovascular Theater, Level 2

Moderator(s): Duk-Woo Park, Alan C. Yeung
Panelist(s): Ziad A. Ali, Adrian P. Banning, Scott Harding, Mamas Mamas, Yoshinobu Murasato, Bruno Scheller, Pieter Smits

• Revascularization for Left Main Disease: Updated Data, Global Guidelines and Beyond
  Seung-Jung Park
• OMT First With ISCHEMIA Trial: Clinical Implications and Patient Selection for Multi-Vessel PCI
  Sripal Bangalore
• Panel Discussion I

Debate: PCI vs. Surgery
Left Main & Multi-Vessel Disease: Updates on Revascularization Strategy in 2024

• PCI Is Enough. - When PCI Should Not Be Standard Treatment
  Duk-Woo Park
• Surgery Is Still Better. - PCI Will Never Surpass CABG.
  David Paul Taggart
• Panel Discussion ll

Master's Case and Review

• Case 1. Practical Issue of Left Main & Multi-Vessel PCI: Make it Simple!
  Seung-Jung Park
• Case 2. Choosing Wisely: FFR vs. Anatomy-guided Left Main PCI -The Rationale of the FATE-MAIN Trial
  Do-Yoon Kang
• Case 3. Challenging Treatment in Left Main In-stent Restenosis
  Bruno Scheller
• Case 4. Multi-Vessel PCI in Acute Coronary Syndromes
  Shamir R. Mehta
• Panel Discussion lll